Local reactogenicity in recipients of the AMA1-C1 vaccine. The percentages of volunteers who experienced injection site erythema (A), induration (B), or tenderness (C) after the first (black bar), second (gray bar), and third (white bar) immunizations with 5 μg, 20 μg, or 80 μg of AMA1-C1 are presented.